{"schema_version":"secwatch.filing_event.v1","accession":"0001055726-25-000045","form_type":"8-K","ticker":"INO","cik":"0001055726","company_name":"INOVIO PHARMACEUTICALS, INC.","filed_at":"2025-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.342339+00:00","generated_at":"2026-05-20T17:19:27.282772+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Inovio shareholders elect eight directors, ratify auditor, approve executive compensation and equity plan","bullets":["Eight directors elected: each received 7.3M-8.4M votes for, 0.6M-1.7M withheld, 11M broker non-votes.","Ernst & Young ratified as auditor for FY2025: 19.3M for, 0.6M against, 0.2M abstain.","Advisory say-on-pay passed: 7.9M for, 1.1M against, 0.2M abstain, 11M broker non-votes.","Amendment and restatement of 2023 Omnibus Incentive Plan approved: 7.8M for, 1.2M against, 0.1M abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001055726-25-000045","json":"https://secwatch.observer/filing/0001055726-25-000045.json","markdown":"https://secwatch.observer/filing/0001055726-25-000045.md","text":"https://secwatch.observer/filing/0001055726-25-000045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000045/0001055726-25-000045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000045/ino-20250520.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T17:19:27.282772+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}